Absci Corp (ABSI): Capital Expenditures
$1.11M
Year ended 2025-12-31
$890.0K
Trailing 12 months to 2026-06-30
-59.1%
3-year compound annual growth
-12.7%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.11M | +174.0% | 2026-03-24, From 2025-01-01 |
| 2024-12-31 | $404.0K | -53.0% | 2026-03-24, From 2024-01-01 |
| 2023-12-31 | $860.0K | -94.7% | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | $16.18M | -57.5% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $38.05M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $2.18M | n/a | 2022-03-22, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Absci Corp (ABSI) | 2025-12-31 | $1.11M | +174.0% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $454 | -98.6% |
| OneMedNet Corp (ONMD) | 2025-12-31 | $13.0K | -74.5% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $60.6K | -23.4% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $62.0K | n/a |
| OmniAb, Inc. (OABI) | 2025-12-31 | $565.0K | -69.9% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $1.77M | +7.1% |
| NRC Health (NRC) | 2025-12-31 | $10.71M | -30.7% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $31.36M | -14.2% |
Compare ABSI, ISPC, ONMD, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗